Important Safety Information
Full Prescribing Information
Patient Package Insert
Instructions For Use
There are a lot of online resources available for people living with pulmonary arterial hypertension (PAH). The links below provide additional education, resources and support.
Living PAH is dedicated to empowering people who are living with PAH and their loved ones by providing the most up-to-date information on the disease and treatment, along with a variety of support services, to help manage the challenges of living with PAH.
For more information, visit www.livingpah.com.
Caring Voice Coalition (CVC) is an independent, national, nonprofit organization dedicated to helping patients affected by chronic disease. CVC supports patients in need through co-pay and premium assistance.
CVC’s Financial Assistance Program may pay for a portion or all of a patient’s costs under the patient’s health insurance plan.
Financial assistance is available for eligible patients who cannot afford:
For more information on CVC’s Financial Assistance Program, call 1-888-267-1440 or visit www.caringvoice.org.
PHA is a leading community-based organization for patients with PAH. Its mission is to find ways to prevent and cure PAH, while providing hope to the community of affected individuals. To that end, the PHA offers the following services:
For more information, visit www.PHAssociation.org.
NHLBI is part of the National Institutes of Health (NIH), the agency of the U.S. Department of Health and Human Services that is largely responsible for conducting medical research. The NHLBI website has easy-to-understand information about various diseases that affect the heart and lungs. To learn more about PAH, visit www.nhlbi.nih.gov and search for PAH.
Founded in 1924, the AHA is the nation’s oldest and largest voluntary health organization dedicated to building healthier lives, free of heart disease and stroke. To help prevent, treat and defeat these diseases—America’s #1 and #3 killers—the AHA funds cutting-edge research, conducts lifesaving public and professional educational programs, and advocates for public health. To learn more, or to join the AHA in helping all Americans, call 1-800-AHA-USA1.
For more information, visit www.americanheart.org.
ACHA is a nonprofit organization seeking to improve the quality of life and extend the lives of people with congenital heart defects through education, outreach, advocacy, and promotion of research.
For more information, visit www.achaheart.org.
Tyvaso is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH) (WHO Group 1), which is high blood pressure in the arteries of your lungs. Tyvaso can improve exercise ability in people who also take bosentan (an endothelin receptor antagonist) or sildenafil (a phosphodiesterase-5 inhibitor). The effects decrease over 4 hours; treatment timing can be adjusted for planned activities.
Studies establishing effectiveness included predominately patients with NYHA Functional Class III symptoms and etiologies of idiopathic or heritable PAH (56%) or PAH associated with connective tissue diseases (33%).
Other medical conditions and medicines may affect your use of Tyvaso by increasing the risk of side effects or decreasing effectiveness. It is important to tell your doctor about your medical conditions and any medicines you may be taking, including:
The most common side effects of Tyvaso are coughing, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), and fainting or loss of consciousness. These are not all the possible side effects of Tyvaso. Tell your doctor about any side effects that bother you or do not go away. Your doctor may be able to help you manage the side effects.
For more information about Tyvaso, please see the Full Prescribing Information, Patient Package Insert, and the Tyvaso Inhalation System Instructions for Use Manual. Questions? Call the Customer Service Line at 1-877-UNITHER (1-877-864-8437).
Click "CONTINUE" to proceed or "RETURN" to return to TYVASO.com
The content of the linked site is the sole responsibility of the site provider. United Therapeutics Corporation does not control or endorse this third-party site.
Click "CONTINUE" to proceed or "RETURN" to return to TYVASO.com
The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a U.S. healthcare professional, please click "RETURN" to return to the consumer section of the site.
Yes, I am a U.S. healthcare professional and would like to continue.